Biogen (BIIB) PT Lowered to $350 at SVB Leerink, Following Dissapointing Drug Trial Results
Tweet Send to a Friend
SVB Leerink analyst Marc H ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
